An MRI-detection method for HCC was developed, based on the presence of high concentrations of AFP and glypican-3 in the cytoplasm and on the surface of tumor cells, respectively, compared to healthy cells. This evidence concerns the gene GPC3 and hepatocellular carcinoma.